Related Experiment Video
Updated: Jun 6, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Radiotherapy in small-cell lung cancer
Hatim Husain1, Christine Hann, Russell Hales
1Department of Medical Oncology, The Johns Hopkins University, School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Oncology (Williston Park, N.Y.)
|December 16, 2010
Summary
Radiotherapy is key for treating limited-stage small cell lung cancer (SCLC) and emerging for extensive-stage SCLC. Research is exploring novel targeted therapies and oncolytic viruses for SCLC management.
Area of Science:
- Oncology
- Radiation Oncology
- Molecular Biology
Background:
- Radiotherapy is integral to treating limited-stage small cell lung cancer (LS-SCLC) and shows promise in extensive-stage SCLC (ES-SCLC).
- Recent advancements in SCLC management are driven by refining radiotherapy's role.
- Ongoing research focuses on novel therapeutic strategies.
Discussion:
- Targeting specific signaling pathways like Hedgehog, c-MET, IGFR-1, mTOR, VEGF, and p53/Bcl-2 is a major research focus.
- Novel therapeutic approaches include oncolytic viruses targeting neuroendocrine cells and CD56-targeted drug delivery.
- These innovative treatments are currently in clinical investigation.
Key Insights:
- Refined radiotherapy techniques are improving SCLC treatment outcomes.
- Targeted molecular therapies offer new avenues for SCLC management.
- Novel drug delivery systems and oncolytic viruses represent promising future directions.
Outlook:
- Clinical trials are underway for many novel SCLC therapies.
- Results from ongoing investigations are anticipated in the coming years.
- The future of SCLC treatment will likely involve a combination of advanced radiotherapy and targeted molecular therapies.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...